D. A. Carlow

发表

Blood—Brain Barrier Permeability Precedes Senile Plaque Formation in an Alzheimer Disease Model

D. Dickstein, W. Jefferies, Maki Ujiie, 2003 .

Formation in Activated CD 8 T Cells-Glycan Branching and P-Selectin Ligand O IL-2 ,4 , and-15 Differentially Regulate and

S. Corbel, D. A. Carlow, H. Ziltener, 2001 .

IL-2, -4, and -15 Differentially Regulate O-Glycan Branching and P-Selectin Ligand Formation in Activated CD8 T Cells1

S. Corbel, D. A. Carlow, H. Ziltener, 2001, The Journal of Immunology.

Absence of CD43 Fails to Alter T Cell Development and Responsiveness1

S. Corbel, D. A. Carlow, H. Ziltener, 2001, The Journal of Immunology.

Affected by Glycosylation Epitope Shared by CD 43 Is Differentially A Novel CD 8 T Cell-Restricted CD 45 RB

D. A. Carlow, B. Ardman, 1999 .

A novel CD8 T cell-restricted CD45RB epitope shared by CD43 is differentially affected by glycosylation.

D. A. Carlow, H. Ziltener, B. Ardman, 1999, Journal of immunology.

T cell idiotypes recognizing self‐major histocompatibility complex molecules: H‐2 specificity, allotype linkage, and expression on functional T cell populations

B. Elliott, Z. Nagy, D. A. Carlow, 1982, European journal of immunology.

Recruitment of adult thymic progenitors is regulated by P-selectin and its ligand PSGL-1

F. Rossi, J. Merzaban, S. Corbel, 2005, Nature Immunology.

P2-044 Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model

D. Dickstein, W. Jefferies, Maki Ujiie, 2004, Neurobiology of Aging.

A cell-extrinsic ligand acquired by activated T cells in lymph node can bridge L-selectin and P-selectin

D. A. Carlow, H. Ziltener, Michelle C. Tra, 2018, PloS one.

Activated CD8 T cells express two distinct P-Selectin Ligands

D. A. Carlow, H. Ziltener, Michelle C. Tra, 2017, bioRxiv.

Vitro but Not Required In Vivo CD8 T Cells: IL-2 and IL-12 Are Active In Inducing P-Selectin Ligand Formation in

D. A. Carlow, Michael J. Williams, J. Hermann, 2017 .

PSGL‐1 function in immunity and steady state homeostasis

W. Seo, D. A. Carlow, H. Ziltener, 2009, Immunological reviews.

Interaction of the selectin ligand PSGL-1 with chemokines CCL21 and CCL19 facilitates efficient homing of T cells to secondary lymphoid organs

J. Merzaban, J. Rivera-Nieves, S. Rosen, 2007, Nature Immunology.

Inducing P-Selectin Ligand Formation in CD8 T Cells: IL-2 and IL-12 Are Active In Vitro but Not Required In Vivo1

D. A. Carlow, H. Ziltener, Michael J. Williams, 2005, The Journal of Immunology.

Vitro but Not Required In Vivo CD 8 T Cells : IL-2 and IL-12 Are Active In Inducing P-Selectin Ligand Formation in Ziltener

D. A. Carlow, Michael J. Williams, 2005 .

Title : Activated CD 8 T cells express two distinct P-Selectin Ligands

D. A. Carlow, H. Ziltener, Michelle C. Tra, 2017 .

Class I (H‐2Kb) gene transfection reduces susceptibility of YAC‐1 lymphoma targets to natural killer cells

J. Roder, A. Czitrom, N. Hozumi, 1990, European journal of immunology.

Interleukin‐7 in the transition of bone marrow progenitors to the thymus

N. Abraham, D. A. Carlow, H. Ziltener, 2017, Immunology and cell biology.

PSGL-1 Regulates the Migration and Proliferation of CD8+ T Cells under Homeostatic Conditions

M. Horwitz, J. Priatel, D. A. Carlow, 2012, The Journal of Immunology.

Perspectives on the role of MHC antigens in normal and malignant cell development.

B. Elliott, D. A. Carlow, A. Rodricks, 1989, Advances in cancer research.

Capacity of CD8+ T Cells to Reject Immunogenic Variants of a Spontaneous Murine Carcinoma: Lack of Non‐Specific (NK1.1+) Effector Mechanisms

H. Pross, D. A. Carlow, A. Barron, 1991, Scandinavian journal of immunology.

In situ augmentation of class I major histocompatibility antigen expression on immunogenic variants of a spontaneous murine mammary carcinoma.

B. Elliott, D. A. Carlow, M. Arnold, 1987, Cancer research.

Homeostatic Conditions T Cells under + Proliferation of CD8 PSGL-1 Regulates the Migration and

M. Horwitz, J. Priatel, D. A. Carlow, 2012 .

Interferon-Induced GTPases TGTP , A Member of a New Family of Specific Antiviral Activity Demonstrated

H. Teh, D. A. Carlow, 1998 .

Failure of expression of class I major histocompatibility antigens to alter tumor immunogenicity of a spontaneous murine carcinoma.

R. Kerbel, B. Elliott, D. A. Carlow, 1989, Journal of the National Cancer Institute.

Differential activation of phospholipase C-gamma 1 and mitogen-activated protein kinase in naive and antigen-primed CD4 T cells by the peptide/MHC ligand.

H. Teh, D. A. Carlow, P. Orchansky, 1996, Journal of immunology.

Tumor specific antigens induced by mutagens and DNA hypomethylating agents: implications for the immunobiology of neoplasia

R. Kerbel, P. Frost, B. Elliott, 1986 .

Demonstration of a correlation between tumor cell H-2 antigen content, immunogenicity, and tumorigenicity using lectin-resistant tumor variants.

J. Dennis, R. Kerbel, D. A. Carlow, 1981, Cancer research.

Possible epigenetic mechanisms of tumor progression: Induction of high‐frequency heritable but phenotypically unstable changes in the tumorigenic and metastatic properties of tumor cell populations by 5‐azacytidine treatment

R. Kerbel, P. Frost, B. Elliott, 1984, Journal of cellular physiology. Supplement.

Isolation of a gene encoding a developmentally regulated T cell-specific protein with a guanine nucleotide triphosphate-binding motif.

J. Marth, H. Teh, D. A. Carlow, 1995, Journal of immunology.

Specific antiviral activity demonstrated by TGTP, a member of a new family of interferon-induced GTPases.

H. Teh, D. A. Carlow, S. Teh, 1998, Journal of immunology.

Deletion of antigen-specific immature thymocytes by dendritic cells requires LFA-1/ICAM interactions.

H. Teh, D. A. Carlow, S. Teh, 1992, Journal of immunology.

Identification and Functional Characterization of Voltage-dependent Calcium Channels in T Lymphocytes*

W. Jefferies, M. Kotturi, D. A. Carlow, 2003, Journal of Biological Chemistry.

Peripheral tolerance through clonal deletion of mature CD4-CD8+ T cells.

R. Miller, H. Teh, D. A. Carlow, 1992, International immunology.

Participation of CD4 coreceptor molecules in T-cell repertoire selection

R. Perlmutter, D. Littman, K. Forbush, 1991, Nature.

Disruption of CD8‐dependent negative and positive selection of thymocytes is correlated with a decreased association between CD8 and the protein tyrosine kinase, p56lck

R. Perlmutter, D. Littman, K. Forbush, 1992, European journal of immunology.

Lymphocytes in the Peritoneum Home to the Omentum and Are Activated by Resident Dendritic Cells1

M. Gold, D. A. Carlow, H. Ziltener, 2009, The Journal of Immunology.

Enhanced expression of class I major histocompatibility complex gene (Dk) products on immunogenic variants of a spontaneous murine carcinoma.

R. Kerbel, B. Elliott, D. A. Carlow, 1985, Journal of the National Cancer Institute.

CD43 Deficiency Has No Impact in Competitive In Vivo Assays of Neutrophil or Activated T Cell Recruitment Efficiency1

D. A. Carlow, H. Ziltener, 2006, The Journal of Immunology.

Modulation of O-Glycans and N-Glycans on Murine CD8 T Cells Fails to Alter Annexin V Ligand Induction by Galectin 11

D. A. Carlow, H. Ziltener, Michael J. Williams, 2003, The Journal of Immunology.

Altered thymocyte development resulting from expressing a deleting ligand on selecting thymic epithelium.

H. Teh, D. A. Carlow, S. Teh, 1992, Journal of immunology.

Topical Adjuvant Application during Subcutaneous Vaccination Promotes Resident Memory T Cell Generation

D. A. Carlow, J. Dutz, Jacqueline C Y Lai, 2019, The Journal of Immunology.

CD43 in T cell–DC conjugate formation?

D. A. Carlow, H. Ziltener, 2001, Nature Immunology.

Cancer Immunology: Innovative Approaches to Therapy

R. Herberman, D. A. Carlow, Bruce E. Elliott, 1986, Cancer Treatment and Research.

PSGL‐1 function in immunity and steady state homeostasis

W. Seo, D. A. Carlow, H. Ziltener, 2009, Immunological reviews.

Cancer Immunology: Innovative Approaches to Therapy

D. A. Carlow, Bruce E. Elliott, 1986, Cancer Treatment and Research.

Cutaneous CpG adjuvant conditioning to enhance vaccine responses.

M. Sadarangani, T. Kollmann, D. A. Carlow, 2022, Vaccine.